Open AccessLACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S‑1
Author(s) -
Fang Yang,
Zhiqiang Yan,
Wei Nie,
Zeying Liu,
Xingzhen Cheng,
Wei Wang,
Chunyan Shao,
Gui Fu,
Yanni Yu
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12731
Subject(s) - oxaliplatin , oncogene , medicine , cancer , molecular medicine , chemotherapy , immunohistochemistry , biomarker , oncology , gastroenterology , pathology , cancer research , cell cycle , colorectal cancer , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom